17-7393206-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_020360.4(PLSCR3):c.445G>A(p.Val149Met) variant causes a missense change. The variant allele was found at a frequency of 0.000224 in 1,554,712 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00023 ( 0 hom. )
Consequence
PLSCR3
NM_020360.4 missense
NM_020360.4 missense
Scores
4
9
5
Clinical Significance
Conservation
PhyloP100: 4.55
Genes affected
PLSCR3 (HGNC:16495): (phospholipid scramblase 3) Enables several functions, including calcium-dependent protein binding activity; metal ion binding activity; and phospholipid scramblase activity. Involved in several processes, including cardiolipin biosynthetic process; regulation of apoptotic process; and regulation of release of cytochrome c from mitochondria. Located in cytosol; mitochondrion; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
TMEM256-PLSCR3 (HGNC:49186): (TMEM256-PLSCR3 readthrough (NMD candidate)) This locus represents naturally occurring read-through transcription between the neighboring chromosome 17 open reading frame 61 (C17orf61) and phospholipid scramblase 3 (PLSCR3) genes. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is unlikely to produce a protein product. [provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.744
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLSCR3 | NM_020360.4 | c.445G>A | p.Val149Met | missense_variant | 5/8 | ENST00000619711.5 | NP_065093.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLSCR3 | ENST00000619711.5 | c.445G>A | p.Val149Met | missense_variant | 5/8 | 5 | NM_020360.4 | ENSP00000483743.2 | ||
TMEM256-PLSCR3 | ENST00000573331.5 | n.*1243G>A | non_coding_transcript_exon_variant | 8/11 | 2 | ENSP00000466104.1 | ||||
TMEM256-PLSCR3 | ENST00000573331.5 | n.*1243G>A | 3_prime_UTR_variant | 8/11 | 2 | ENSP00000466104.1 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152000Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
30
AN:
152000
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000181 AC: 30AN: 165446Hom.: 0 AF XY: 0.000150 AC XY: 14AN XY: 93298
GnomAD3 exomes
AF:
AC:
30
AN:
165446
Hom.:
AF XY:
AC XY:
14
AN XY:
93298
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000227 AC: 318AN: 1402598Hom.: 0 Cov.: 36 AF XY: 0.000214 AC XY: 149AN XY: 695500
GnomAD4 exome
AF:
AC:
318
AN:
1402598
Hom.:
Cov.:
36
AF XY:
AC XY:
149
AN XY:
695500
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000197 AC: 30AN: 152114Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74368
GnomAD4 genome
AF:
AC:
30
AN:
152114
Hom.:
Cov.:
32
AF XY:
AC XY:
12
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
13
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 15, 2021 | The c.445G>A (p.V149M) alteration is located in exon 5 (coding exon 4) of the PLSCR3 gene. This alteration results from a G to A substitution at nucleotide position 445, causing the valine (V) at amino acid position 149 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M;M;M;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;.;.;.;.
REVEL
Uncertain
Sift
Pathogenic
D;D;.;.;.;.
Sift4G
Uncertain
D;D;D;D;D;D
Polyphen
D;D;D;D;.;.
Vest4
MutPred
Gain of catalytic residue at V149 (P = 0.0297);Gain of catalytic residue at V149 (P = 0.0297);Gain of catalytic residue at V149 (P = 0.0297);Gain of catalytic residue at V149 (P = 0.0297);Gain of catalytic residue at V149 (P = 0.0297);.;
MVP
MPC
1.5
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at